학술논문
Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer
Document Type
Article
Author
Source
In: Haematologica . (Haematologica, April 2024, 109(4):1128-1138)
Subject
Language
English
ISSN
15928721
03906078
03906078